Skip to main content
SpringerLink
Log in

The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Hip osteoarthritis (OA) is usually managed with systemic treatments such as nonsteroidal anti-inflammatory drugs (NSAIDs) and/or symptomatic slow-acting drugs. Unfortunately, many patients either cannot tolerate NSAIDs or suffer serious, even fatal, NSAID-induced side effects, predominantly gastrointestinal ulceration and bleeding. Viscosupplementation, which aims to restore physiological and rheological features of the synovial fluid, is a well-accepted therapeutic option in knee OA patients, but limited data exist in the literature about its potential benefit for the treatment of hip OA. The purpose of this study is to observe the effects of hylan G-F 20 administered through ultrasound (US)-guided intra-articular (IA) injections in patients with symptomatic hip OA. We treated 30 patients with symptomatic hip OA. Under US guidance, 7 patients received one injection, 21 patients had two injections, and 2 patients received three injections, each with 2 ml of hylan G-F 20. Lequesne index, VAS scale of hip pain, and NSAID consumption were evaluated at baseline as well as 2 and 6 months after the beginning of the treatment. No systemic adverse events were observed. Lequesne index, VAS pain score, and NSAID consumption showed a reduction that was statistically significant to the baseline. The present observation suggests the potentiality for the safety and efficacy of hylan G-F 20 injected under US guidance in patients with symptomatic hip OA. Further controlled studies are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Balazs EA, Denlinger JL (2003) Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 20(39):2–9

    Google Scholar 

  2. Altman RD, Hochberg MC, Moskowitz RW, Schnitzer TJ (2000) Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 43:1905–1915

    Article  PubMed  Google Scholar 

  3. Espallargues M, Pons JM (2003) Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis: a systematic review. Int J Technol Assess Health Care 19(1):41–56

    Article  PubMed  Google Scholar 

  4. Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N (2002) A prospective, randomized, pragmatic health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 1 of 2): clinical results. Osteoarthritis Cartilage 10:506–517

    Article  PubMed  Google Scholar 

  5. Adams ME, Atkinson MH, Lussier A, Schulz JI, Siminovitch KA, Wade JP et al (1995) The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F alone, hylan G-F 20 with nonsteroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 3:213–226

    Article  PubMed  CAS  Google Scholar 

  6. Tamir E, Robinson D, Koren R, Agar G (2001) Intra-articular hyaluronan for the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled study. Clin Exp Rheumatol 19:265–270

    PubMed  CAS  Google Scholar 

  7. Kolarz G, Kotz R, Hochmayer I (2003) Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 32(5):310–319

    Article  PubMed  CAS  Google Scholar 

  8. Wobig M, Dickhut A, Maier R, Vetter G (1998) Viscosupplementation with hylan G-F 20: a 26 week controlled trial of efficacy and safety in the osteoarthritis knee. Clin Ther 20:410–423

    Article  PubMed  CAS  Google Scholar 

  9. Dickson DJ, Hosie G, English JR et al (2001) A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Res 4:41–52

    Google Scholar 

  10. Brocq O, Tran G, Breuil U, Grisot C, Flory P, Euller-Zuegler L (2002) Hip osteoarthritis: short term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 69(4):388–391

    Article  PubMed  Google Scholar 

  11. Migliore A, Martin Martin LS, Alimonti A et al (2003) Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 11:305–306

    Article  PubMed  CAS  Google Scholar 

  12. Migliore A, Martin Martin LS, Valente C, Alimonti A, Bernardini A, Monno D, Tormenta S (2002) Intra-articular treatment with Hylan G-F 20 (Synvisc) reduces NSAIDS consumption in patients with symptomatic osteoarthritis of the hip: preliminary clinical observations. Osteoporosis Int 13(3):S20

    Google Scholar 

  13. Conrozier T, Bertin P, Mathieu P, Charlot J, Bailleul F, Treves R, Vignon E, Chevalier X (2003) Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open label, multicentre, pilot study. Clin Exp Rheumatol 21 605–610

    PubMed  CAS  Google Scholar 

  14. Leopold SS, Battista V, Oliverio JA (2001) Safety and efficacy of intraarticular hip injection using anatomic landmarks. Clin Orthop Relat Res Oct(391):192–197

    Article  Google Scholar 

  15. Jackson DW, Evans NA, and Thomas BM (2002) Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 84A:1522–1527

    Google Scholar 

  16. Qvistgaard E, Kristoffersen H, Terslev L, Danneskiold-Samsoe B, Torp-pedersen S, Bliddal H (2001) Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthritis Cartilage 9:512–517

    Article  PubMed  CAS  Google Scholar 

  17. Migliore A, Tormenta S, Martin LS, Valente C, Massafra U, Granata M, Alimonti A (2004) Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol Dec 9 (Epub ahead of print)

  18. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502

    Article  PubMed  CAS  Google Scholar 

  19. Lequesne MG (1997) The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 24(4):779–781

    PubMed  CAS  Google Scholar 

  20. Sturkenboom MC, Romano F, Simon G, Correa-Leite ML, Villa M, Nicolosi Á, Borgnolo G, White-Porro G, Mannino S (2002) The iatrogenic costs of NSAID therapy: a population study. Arthritis Rheum 47(2):132–140

    Article  PubMed  Google Scholar 

  21. Page J, Henry D (2000) Consumption of NSAIDs and development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 160:777–784

    Article  PubMed  CAS  Google Scholar 

  22. Larsen NE, Balazs EA (1991) Drug delivery system using hyaluronan and its derivatives. Adv Drug Deliv Rev 7:279–293

    Article  CAS  Google Scholar 

  23. Weiss C, Band P (1995) Musculokeletal applications of hyaluronan and hylan. Potential uses in the foot and ankle. Clin Podiatr Med Surg 12:497–517

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Center S. Pietro Hospital, Fatebenefratelli-AFaR, Rome, Italy

    Alberto Migliore, Sandro Tormenta, Luis Severino Martin Martin, Francesca Iannessi, Umberto Massafra, Emilia Carloni, Danilo Monno, Andrea Alimonti & Mauro Granata

  2. Department of Internal Medicine “S.Pietro-Fatebenefratelli” Hospital, v. Cassia 600, 00189, Rome, Italy

    Alberto Migliore, Umberto Massafra, Emilia Carloni & Andrea Alimonti

  3. Department of Radiology, “S.Pietro-Fatebenefratelli” Hospital, Rome, Italy

    Sandro Tormenta & Francesca Iannessi

  4. Department of Internal Medicine, “Regina apostolorum”, Albano-Rome, Italy

    Luis Severino Martin Martin

  5. Department of Internal Medicine, “S.Giovanni Calibita-Fatebenefratelli” Hospital, Rome, Italy

    Danilo Monno

  6. Department of Rheumatology, “San Filippo Neri” Hospital, Rome, Italy

    Mauro Granata

Authors
  1. Alberto Migliore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandro Tormenta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luis Severino Martin Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francesca Iannessi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Umberto Massafra
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Emilia Carloni
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Danilo Monno
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Andrea Alimonti
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mauro Granata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alberto Migliore.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Migliore, A., Tormenta, S., Martin Martin, L.S. et al. The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clin Rheumatol 25, 389–393 (2006). https://doi.org/10.1007/s10067-005-0052-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-005-0052-x

Keywords

Search

Navigation